4//SEC Filing
Mills Kenneth T. 4
Accession 0001562180-24-006146
CIK 0001590877other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:58 PM ET
Size
8.0 KB
Accession
0001562180-24-006146
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Mills Kenneth T.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-08$0.85/sh+36,316$30,869→ 444,351 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-08-08−36,316→ 0 totalExercise: $0.85Exp: 2024-09-24→ Common Stock (36,316 underlying)
Footnotes (1)
- [F1]The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001652824
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:58 PM ET
- Size
- 8.0 KB